- HK$2.89bn
- HK$2.60bn
- CNY578.81m
- 35
- 44
- 52
- 38
Annual income statement for BaTeLab Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 88.7 | 213 | 353 | 464 | 579 |
| Cost of Revenue | |||||
| Gross Profit | 48.7 | 120 | 199 | 257 | 307 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 70.7 | 152 | 254 | 350 | 405 |
| Operating Profit | 18 | 60.8 | 98.5 | 113 | 174 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | 14 | 57 | 96.8 | 109 | 166 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 14 | 57 | 95.3 | 109 | 167 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 14 | 57 | 95.3 | 109 | 167 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 14 | 57 | 95.3 | 109 | 167 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.23 | 0.95 | 1.59 | 1.84 | 2.78 |